Acute lymphoblastic leukemia

Main variants of the disease course

Although the various types of these neoplasms share very similar clinical and morphological features, two main variants of the course are classically distinguished, depending on the lineage of the tumor cells.

1. Pre-B-lymphoblastic tumors

This type is characterized by a primary presentation strictly as a classic leukemia. The bone marrow is involved in the pathological process, showing massive infiltration by tumor elements. As a result, immature blast cells inevitably enter the systemic circulation and are massively detected in peripheral blood during laboratory tests.

1. Pre-T-lymphoblastic tumors

This variant is distinguished by its primary localization. Since normal T-lymphocyte differentiation occurs in the thymus, it frequently serves as the primary site of tumor origin. The disease manifests as a mass lesion—a massive tumor infiltrate in the mediastinum. Subsequently, the pathological process does not remain localized and rapidly transforms into systemic leukemia with involvement of the bone marrow and other organs.

Clinical manifestations and hematopoietic failure

An important feature of acute lymphoblastic leukemias is that the clinical picture is practically independent of cytogenesis (i.e., whether the tumor developed from B- or T-precursors). The disease always has a pronounced acute onset.

All main symptoms are directly caused by the development of severe normal hematopoietic failure. Proliferating lymphoblasts crowd out normal hematopoietic cell lines, leading to the following consequences:

• Anemia (decreased erythrocyte count and hemoglobin);
• Bleeding (due to suppression of the megakaryocytic lineage and decreased platelet levels);
• Recurrent infections (due to a lack of mature, functionally competent leukocytes).

In addition, tumor cells are capable of migration. Specific leukemic infiltration of various internal organs develops. One of the most characteristic and agonizing symptoms for the patient is severe bone pain—it arises precisely because of dense infiltration of the bone marrow space by actively dividing tumor cells.

Central nervous system involvement (Neuroleukemia)

Specific CNS involvement, or neuroleukemia, can occur in any form of leukemia, but it is most characteristic of the lymphoblastic variant and poses a serious clinical challenge.

Pathogenesis of neuroleukemia: Tumor cells penetrate the structures of the central nervous system and begin to actively accumulate in the subarachnoid space, causing dense infiltration of the pia mater.

Therapeutic challenges and consequences: The main problem lies in the presence of the blood-brain barrier. Standard administration of cytotoxic drugs does not achieve effective therapeutic concentrations in the cerebrospinal fluid (CSF). The only exception is ultra-high doses of methotrexate. Consequently, lymphoblasts that have entered the CNS successfully evade the destructive action of chemotherapy drugs. As a result, the central nervous system becomes a sort of "sanctuary" for the tumor, representing a potential reservoir and center from which a disease relapse is highly likely to develop in the future.

Basics of diagnostics

Making an accurate diagnosis when acute lymphoblastic leukemia is suspected brooks no delay due to the extremely rapid progression of the pathology. The diagnostic workup is based on three main pillars:

1. Thorough assessment of clinical symptoms (identification of signs of acute onset, anemia, hemorrhagic syndrome, infections, and bone pain).
2. Analysis of the peripheral blood picture (search for blast cells and signs of suppression of normal hematopoietic lineages).
3. Examination of the bone marrow aspirate (the key method allowing visualization of massive lymphoblastic infiltration and definitive verification of the diagnosis).

Class and exam questions

What else to study on this topic

• Mechanisms of hematopoietic failure development in leukemias
• Cytological picture of peripheral blood in the presence of blast cells
• Pharmacokinetics of methotrexate and its penetration into the cerebrospinal fluid
• Differential diagnosis of a massive mediastinal infiltrate
• Pathophysiology of leptomeningeal tumor infiltration

Other topics in Hematopoietic System Diseases

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.